Open AccessDOAJ SealDOAJCrossrefOpenAlex
Translational Oncology
Metadata for this journal is being automatically enriched from connected scholarly data sources.
Journal information
- Publisher
- Elsevier
- Subjects
- bench-to-bedside cancer research · Cancer Cells and Metastasis · Cancer Genomics and Diagnostics · Cancer Immunotherapy and Biomarkers · Cancer-related molecular mechanisms research · Cancer, Hypoxia, and Metabolism · experimental and early-phase oncology · Ferroptosis and cancer prognosis · mechanisms of therapeutic response and resistance · MicroRNA in disease regulation · molecularly guided clinical trials · Neoplasms. Tumors. Oncology. Including cancer and carcinogens · precision oncology and biomarker development · RC254-282 · RNA modifications and cancer · translational cancer therapeutics
- Country
- NL
- Languages
- EN
- ISSN
- 1944-7124
- E-ISSN
- 1936-5233
- ISSN-L
- 1936-5233
- Open access
- Yes
- OA since
- 2008
- Publication years
- 1955–2026
- APC (summary)
- —
- Website
- Visit journal ↗
Journal Classification
Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.
- Classification
- Field / Subfield
- Primary Field
- Medicine
- Primary Subfield
- Oncology
- Domain
- Health Sciences
- Confidence
- High
- Publications classified
- 774
- Classification version
- OAJF Classification v1.1
APC records
- OPENALEX · 2026
- 3,170 EUR
- OPENALEX · 2026
- 2,710 GBP
- OPENALEX · 2026
- 420,460 JPY
- OPENALEX · 2026
- 3,390 USD
- DOAJ · 2026
- 3,880 USD